Becanex GmbH was officially founded in January of 2019 in Berlin, Germany. Our journey, however, began as early as 2011 with a small extraction prototype in a basement in Wageningen, The Netherlands. Since then it has evolved into a full-fledged high-tech start-up with its very own pharma-GMP production facility in Berlin-Adlershof and R&D department on the campus of Wageningen University - the world's leading university for food and process technology. In 2023, Becanex will finalize its full transition to the medical cannabis market. A decade of experience in cannabinoid extraction should provide us with a solid foundation for entering the medical market while meeting legal, medical, and patient needs. The production process that Becanex invented – and called one-step-extraction – aims to disrupt the medical cannabis industry by gently extracting all valuable molecules out of cannabis in a single step. After years of research by our team, we managed to create a plant-identical cannabis extract that mirrors the plant profile of cannabis strains but leaving out unwanted parts as waxes and chlorophyll. Thus, offering patients and physicians all the benefits of smoking cannabis flowers, but without the harms related to conventional smoking methods. To further optimize dosing and delivery of plant-identical cannabis extract, Becanex works together with leaders in their respective fields of drug delivery systems. As a result, physicians will be able to prescribe from a variety of drug delivery methods that best meet the needs of their patients in terms of reaching and staying within the therapeutic window.